All manuscripts
Publications T-Cells G-Rex®10

High throughput, automated and fully contained cytokine release assay using primary human CD4+ T cells

Published Journal SLAS Discovery

Share
7 pages High throughput, automated and fully contained cytokine release assay using primary human CD4+ T cells — SLAS Discovery, 2026

Overview

Pfizer describes an automated, fully contained cytokine release assay using primary human CD4+ T cells, screening up to 15,000 compounds weekly. Isolated T cells expand 6- to 8-fold in 7 days. G-Rex® 10 open-system flasks (Wilson Wolf) supply the 4-day expansion step of the protocol.

What this paper found

A fully contained, automated cytokine release assay using primary human CD4+ T cells was built to support medium- to high-throughput compound screening. Purchased CD4+ T cells are activated with anti-CD3/CD28 beads for 3 days, then expanded in a G-Rex® 10 flask to reach a 6- to 8-fold increase by day 7. One vial of 1.5E7 cells supplies roughly 3,000 assay wells. Cells are dispensed at 30,000 per well into 384-well plates with compound, restimulated with ImmunoCult, and IL-2 in the supernatant is read by HTRF after 20 to 24 hours. The assay generated more than 5,600 IC50 curves and 11,000 single-dose datapoints with Z primes above 0.2, and supported discovery of an ITK inhibitor clinical candidate.

Note: The assay is phenotypic, so the authors recommend an orthogonal assay to confirm target specificity.

One vial of CD4 [+] T cells therefore enables the screening of 3000 single-dose compounds or 125 11-point dose-response curves in duplicate per expansion. — Amy L. Brault, Theresa A. Dickinson, Mary Ellen Banker, Ruth F. Sommese, Fabien Vincent, SLAS Discovery

Study details

Authors
Amy L. Brault, Theresa A. Dickinson, Mary Ellen Banker, Ruth F. Sommese, Fabien Vincent
Institution
Discovery Biology and Pharmacology, Pfizer, Groton, CT, USA
Journal
SLAS Discovery
Year
2026
PMID / PMC
PMID: 41871780
G-Rex® model(s)
G-Rex®10
Cell type(s)
T-Cells
Application area
Autoimmune
Study phase
Preclinical

How G-Rex® was used

After 3 days of activation with anti-CD3/CD28 Dynabeads in 24-well plates at 1 million cells/mL, beads are removed magnetically. Cells are diluted to 5×10^5 cells/mL in T cell expansion medium and placed in a G-Rex® 10 flask, with the total volume brought to 40 mL. They are incubated a further 4 days at 37 °C and 5% CO2, giving 7 days in culture in total. A 6 to 8-fold expansion in CD4+ T cell number is expected, and the expanded cells are then used in the IL-2 release assay.

Explore related

Full citation

Brault AL, Dickinson TA, Banker ME, Sommese RF, Vincent F. High throughput, automated and fully contained cytokine release assay using primary human CD4+ T cells. SLAS Discov. 2026;41:100305.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →